3rd Circ. Affirms Win For GSK In Wellbutrin Antitrust Case
By Emma Cueto ( August 9, 2017, 4:33 PM EDT) -- The Third Circuit ruled on Wednesday not to revive a class action lawsuit accusing GlaxoSmithKline PLC of violating antitrust laws with an alleged pay-for-delay settlement with would-be generic manufacturers for the antidepressant Wellbutrin....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.